Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0614720120550090861
Journal of Korean Medical Association
2012 Volume.55 No. 9 p.861 ~ p.868
The role of the KIDS for enhancing drug safety and risk management in Korea
Jung Soo-Youn

Jung Sun-Young
Shin Ju-Young
Park Byung-Joo
Abstract
Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. The Korea Institute of Drug Safety and Risk Management (KIDS) was established in April 2012. The main missions of the KIDS are to collect, analyze, evaluate, and manage adverse drug reaction (ADR) data, develop drug utilization review (DUR) criteria, distribute medication guidelines for health professionals, perform retrospective DUR, and perform causality assessment on ADRs, or signals derived from spontaneous reporting or other sources. The KIDS aims to provide evidence to enhance national health quality through a better drug safety and risk management system in Korea. The purpose of this paper is to suggest possible approaches and the KIDS¡¯s role in strengthening the pharmacovigilance system in Korea.
KEYWORD
Pharmacovigilance, Pharamcoepidemiology, Drug utilization review, Risk management
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed